Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT00903175 · COMPLETED
Trial details
- NCT number
- NCT00903175
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 471
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.